BR
Bobak R. Azamian sold $615K of TARS stock
Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares of TARS stock worth $615K, per an SEC Form 4 filed Jun 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 5 days before it was made public.
TARS has moved +25.8% since the trade date, from $62.55 to $78.68 (Nov 16, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 5 days
- Price since
- +25.8%
- Role
- President/CEO and Board Chair
- Source
- SEC Form 4